Octapharma Plasma, Inc. – FDA Inspection, May 14, 2026

Record Details

This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on May 14, 2026, issued by the Denver District Office, covering biologics.

Company: Octapharma Plasma, Inc.
Inspection Date: May 14, 2026
Product Type: Biologics
Office: Denver District Office
Person: Garrad R. Poole (Investigator)

View Company Profile

ID · 532ae937-43be-48d9-9259-d826a4616ee4

Inspection Facts

Inspection number: 1318224
FDA center: Biologics
Project area: Blood and Blood Products
Outcome: Form 483 issued

FDA Citations

21 CFR 606.60(b)Equipment calibration frequency

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Octapharma Plasma, Inc.

FDA Inspection

Octapharma Plasma, Inc.May 14, 2026